Janux Therapeutics, Inc. (JANX) Stock

Janux Therapeutics, Inc. (JANX) is a Healthcare stock trading at $14.22 (as of 2026-06-18), with a market capitalization of $889.76M and a trailing P/E of -7.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Janux Therapeutics, Inc. is a biopharmaceutical company developing cancer therapies using its Tumor Activated T Cell Engager (TRACTr) platform. It is advancing TRACTr and related immunomodulator programs targeting antigens such as prostate-specific membrane antigen, EGFR, and trophoblast cell surface antigen 2, and a costimulatory bispecific program aimed at PD-L1 and CD28.

Valuation — source: SEC EDGAR (first-party)
Price$14.22
Market Cap$889.76M
P/E Ratio-7.7
EV / EBITDA-5.3
Price / Book0.92
Price / Sales63.15
DCF Value (model)$-22.45
DCF Upside vs Price-257.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$10.00M
Net Margin-1136.3%
Return on Equity-12.2%
Current Ratio17.01
Revenue Growth (YoY)-5.6%
EPS Growth (YoY)43.0%
FCF Growth (YoY)88.5%
Financial Health — source: SEC EDGAR
Altman Z-Score11.74 (safe)
Valuation vs Sector & Industry
Stock P/E-7.7
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-136.9%
vs Industry-144.8%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderRA CAPITAL MANAGEMENT, L.P. ($155.54M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEODavid Alan Campbell
Employees91
CountryUS
IPO Date2021-06-11

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Nektar Therapeutics (NKTR)
  • ArriVent BioPharma, Inc. Common Stock (AVBP)
  • MoonLake Immunotherapeutics (MLTX)
  • Geron Corporation (GERN)
  • Alumis Inc. Common Stock (ALMS)
  • KalVista Pharmaceuticals, Inc. (KALV)
  • ORIC Pharmaceuticals, Inc. (ORIC)
  • Aquestive Therapeutics, Inc. (AQST)
JANX earnings history · JANX institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.